Evidence map›Paper›PMID 24890245›Full record

ArticleThe Milbank quarterly2014

Waiting for the opportune moment: the tobacco industry and marijuana legalization.

Rachel Ann Barry, Heikki Hiilamo, Stanton A Glantz

Abstract readHistorical Article
In one paragraph

Article in The Milbank quarterly, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Cannabis industry campaign expenditures in Colorado, 2005-2021.The International journal on drug policy · 2023
    Review
  6. Observational
  7. Review
  8. Article
  9. Article
  10. Think big about developing the science.Addiction (Abingdon, England) · 2021
    Article
  11. Article
  12. Six policy lessons relevant to cannabis legalization.The American journal of drug and alcohol abuse · 2019
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Confirmation of the trials and tribulations of vaping.Addiction (Abingdon, England) · 2015
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rachel Ann BarryCenter for Tobacco Control Research and Education and Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco.
Heikki Hiilamo
Stanton A Glantz

Funding

ANALYSIS OF TOBACCO INDUSTRY DOCUMENTSR01CA087472 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LING, PAMELA MAY · 2000 to 2018
$12.5M
NCI NIH HHS R01 CA087472
6 · The paper itself

Abstract

contextIn 2012, Washington State and Colorado legalized the recreational use of marijuana, and Uruguay, beginning in 2014, will become the first country to legalize the sale and distribution of marijuana. The challenge facing policymakers and public health advocates is reducing the harms of an ineffective, costly, and discriminatory "war on drugs" while preventing another public health catastrophe similar to tobacco use, which kills 6 million people worldwide each year.

methodsBetween May and December 2013, using the standard snowball research technique, we searched the Legacy Tobacco Documents Library of previously secret tobacco industry documents (http://legacy.library.ucsf.edu).

findingsSince at least the 1970s, tobacco companies have been interested in marijuana and marijuana legalization as both a potential and a rival product. As public opinion shifted and governments began relaxing laws pertaining to marijuana criminalization, the tobacco companies modified their corporate planning strategies to prepare for future consumer demand.

conclusionsPolicymakers and public health advocates must be aware that the tobacco industry or comparable multinational organizations (eg, food and beverage industries) are prepared to enter the marijuana market with the intention of increasing its already widespread use. In order to prevent domination of the market by companies seeking to maximize market size and profits, policymakers should learn from their successes and failures in regulating tobacco.

Indexed as

CannabisLegislation, DrugTobacco IndustryHistory, 20th CenturyHistory, 21st CenturyHumansTobacco ProductsUnited Statescigarettesmarijuanapublic policytobacco industry

Identifiers

PMID24890245
PMCPMC4089369

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.